Literature DB >> 20375220

CD8+ T-cell recognition of human cytomegalovirus latency-associated determinant pUL138.

Siok-Keen Tey1,2, Felicia Goodrum3, Rajiv Khanna2.   

Abstract

Recent studies have shown that long-term persistence of human cytomegalovirus (HCMV) in mononuclear cells of myeloid lineage is dependent on the UL138 open reading frame, which promotes latent infection. Although T-cell recognition of protein antigens from all stages of lytic HCMV infection is well established, it is not clear whether proteins expressed during latent HCMV infection can also be recognized. This study conducted an analysis of T-cell response towards proteins associated with HCMV latency. Ex vivo analysis of T cells from healthy virus carriers revealed a dominant CD8(+) T-cell response to the latency-associated pUL138 protein, which recognized a non-canonical 13 aa epitope in association with HLA-B*3501. These pUL138-specific T cells displayed a range of memory phenotypes that were in general less differentiated than that previously described in T cells specific for HCMV lytic antigens. Antigen-presentation assays revealed that endogenous pUL138 could be presented efficiently by HCMV-infected cells. However, T-cell recognition of pUL138 was dependent on newly synthesized protein, with little presentation from stable, long-lived protein. These data demonstrate that T cells targeting latency-associated protein products exist, although HCMV may limit the presentation of latent proteins, thereby restricting T-cell recognition of latently infected cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375220      PMCID: PMC4091183          DOI: 10.1099/vir.0.020982-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  41 in total

1.  Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome.

Authors:  C A Bolovan-Fritts; E S Mocarski; J A Wiedeman
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

2.  Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells.

Authors:  Allen K L Cheung; Allison Abendroth; Anthony L Cunningham; Barry Slobedman
Journal:  Blood       Date:  2006-08-24       Impact factor: 22.113

3.  Interleukin-4 is needed for the infection of monocytes by human cytomegalovirus.

Authors:  H Kitajima; Y Okubo; J Honda; J Yonemitsu; N Yoshida; T Fumimori; K Oizumi
Journal:  Intervirology       Date:  2001       Impact factor: 1.763

4.  Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

Authors:  P Yotnda; H Onishi; H E Heslop; D Shayakhmetov; A Lieber; M Brenner; A Davis
Journal:  Gene Ther       Date:  2001-06       Impact factor: 5.250

5.  Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus.

Authors:  Mariana Bego; J Maciejewski; S Khaiboullina; G Pari; S St Jeor
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection.

Authors:  Christina Jenkins; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients.

Authors:  C Pouteil-Noble; R Ecochard; G Landrivon; A Donia-Maged; J C Tardy; S Bosshard; S Colon; H Betuel; M Aymard; J L Touraine
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

8.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Authors:  Andrew W Sylwester; Bridget L Mitchell; John B Edgar; Cara Taormina; Christian Pelte; Franziska Ruchti; Paul R Sleath; Kenneth H Grabstein; Nancy A Hosken; Florian Kern; Jay A Nelson; Louis J Picker
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

9.  Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection.

Authors:  Andrew D Hislop; Nicola E Annels; Nancy H Gudgeon; Alison M Leese; Alan B Rickinson
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

10.  Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

Authors:  Judy Tellam; Geoff Connolly; Katherine J Green; John J Miles; Denis J Moss; Scott R Burrows; Rajiv Khanna
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

View more
  12 in total

1.  The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.

Authors:  Thomas Trolle; Curtis P McMurtrey; John Sidney; Wilfried Bardet; Sean C Osborn; Thomas Kaever; Alessandro Sette; William H Hildebrand; Morten Nielsen; Bjoern Peters
Journal:  J Immunol       Date:  2016-01-18       Impact factor: 5.422

Review 2.  The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?

Authors:  Mark R Wills; Emma Poole; Betty Lau; Ben Krishna; John H Sinclair
Journal:  Cell Mol Immunol       Date:  2014-08-18       Impact factor: 11.530

3.  Human herpesvirus diversity is altered in HLA class I binding peptides.

Authors:  William H Palmer; Marco Telford; Arcadi Navarro; Gabriel Santpere; Paul J Norman
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-29       Impact factor: 12.779

4.  The immune response to human CMV.

Authors:  Corinna La Rosa; Don J Diamond
Journal:  Future Virol       Date:  2012-03-01       Impact factor: 1.831

5.  Long and Short Isoforms of the Human Cytomegalovirus UL138 Protein Silence IE Transcription and Promote Latency.

Authors:  Song Hee Lee; Katie Caviness; Emily R Albright; Jeong-Hee Lee; Christopher B Gelbmann; Mike Rak; Felicia Goodrum; Robert F Kalejta
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

6.  Characterization of human cytomegalovirus UL145 and UL136 genes in low-passage clinical isolates from infected Chinese infants.

Authors:  Bo Wang; Jing-Jing Hu; Cui-Fang Yan; Hai-Hao Su; Jun-Cai Ding; Yuan-Yuan Guo; Ning Ye; Shui-Qing Zhang; Xiao-Zhuang Zhang; Shu-Feng Zhou
Journal:  Med Sci Monit       Date:  2011-08

7.  Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation.

Authors:  Pavankumar Reddy Varanasi; Justyna Ogonek; Susanne Luther; Elke Dammann; Michael Stadler; Arnold Ganser; Sylvia Borchers; Lothar Hambach; Eva M Weissinger
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

8.  Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells.

Authors:  Gavin M Mason; Sarah Jackson; Georgina Okecha; Emma Poole; J G Patrick Sissons; John Sinclair; Mark R Wills
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

9.  Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age.

Authors:  A Alejenef; A Pachnio; M Halawi; S E Christmas; P A H Moss; N Khan
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 10.  Human cytomegalovirus manipulation of latently infected cells.

Authors:  John H Sinclair; Matthew B Reeves
Journal:  Viruses       Date:  2013-11-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.